Skip to main content

LGT Group Foundation

SEC CIK
0001911278
Latest filing
Aug 10, 2026

ABT holding history

Abbott Laboratories in every 13F filed by LGT Group Foundation, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q4 2021
Holdings of ABT by LGT Group Foundation, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−2,711−100.0%Sold outHolders
Q1 20262,711$278.3K<0.1%−97−3.5%ReducedHolders
Q4 20252,808$353.2K<0.1%−259−8.4%ReducedHolders
Q3 20253,067$409.4K<0.1%−289−8.6%ReducedHolders
Q2 20253,356$456.4K<0.1%−1,210−26.5%ReducedHolders
Q1 20254,566$605.7K<0.1%−152−3.2%ReducedHolders
Q4 20244,718$533.7K<0.1%−235−4.7%ReducedHolders
Q3 20244,953$562.9K<0.1%−963−16.3%ReducedHolders
Q2 20245,916$614.7K<0.1%+2,088+54.5%AddedHolders
Q1 20243,828$435.1K<0.1%−2,923−43.3%ReducedHolders
Q4 20236,751$745.3K<0.1%+40+0.6%AddedHolders
Q3 20236,711$642.4K<0.1%+2,128+46.4%AddedHolders
Q2 20234,583$499.6K<0.1%−2,036−30.8%ReducedHolders
Q1 20236,619$670.2K<0.1%+427+6.9%AddedHolders
Q4 20226,192$679.8K<0.1%−531−7.9%ReducedHolders
Q3 20226,723$651.0K<0.1%+1,672+33.1%AddedHolders
Q2 20225,051$549.0K<0.1%−10,015−66.5%ReducedHolders
Q1 202215,066$1.79M<0.1%−2,577−14.6%ReducedHolders
Q4 202117,643$2.48M0.1%–No prior filingHolders